Expanding Access Through Innovative Pharmaceutical Solution
Reducing treatment-related side effects, improving quality of life, and helping patients stay on track with therapy care that’s about thriving, not just surviving.
Biosimilars are biologic products that are highly similar to an approved reference product, with no clinically meaningful differences in quality, safety, and efficacy. They are developed through a rigorous comparability exercise, including analytical, non-clinical, and clinical studies, to confirm equivalence to the originator.
Developed by Biocon, these biosimilars support broader patient access to biologic therapies while maintaining established clinical performance.